Low
₹98.01
High
₹102.50
| Previous Close | ₹100.04 |
|---|---|
| Day's Range | ₹98.01 - ₹102.50 |
| Open | ₹99.50 |
| 52 Week Range | ₹59.31 - ₹127.00 |
| Volume | 25,940 |
| Market Cap | ₹0.00 |
| Previous Close | ₹100.00 |
|---|---|
| Day's Range | ₹99.50 - ₹104.00 |
| Open | ₹102.00 |
| 52 Week Range | ₹59.72 - ₹126.95 |
| Volume | 2,362 |
| Market Cap | ₹0.00 |
| Trade Value ( ₹ in Lacs) | 25.95 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 91.76 |
| TTM EPS (₹) | 1.09 |
| P/E Ratio | 32.12 |
| Book Value(₹) | 1.81 |
| PAT Margin (%) | 3.21 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 8.29 |
| Trade Value ( ₹ in Lacs) | 2.36 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 91.76 |
| TTM EPS (₹) | 1.09 |
| P/E Ratio | 32.12 |
| Book Value(₹) | 1.81 |
| PAT Margin (%) | 3.21 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 8.29 |
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 1085.15 | 3756.36 |
| Expenses | N/A | N/A |
| PBT | 86.49 | 176.12 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 54.21 | 117.44 |
| Founded | 1984 |
|---|---|
| Managing Director | Anwar Siraj Daud |
| NSE Symbol | ZIMLAB |
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,42,725.29 | 1,840.50 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,82,775.12 | 6,770.15 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,51,764.01 | 4,575.45 | 3,102.00 - 3,102.00 |
| Apollo Hospitals Enterprise Ltd. | 1,20,200.38 | 8,399.00 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,13,007.26 | 1,412.70 | 1,165.70 - 1,165.70 |
| Dr. Reddy's Laboratories Ltd. | 1,09,098.01 | 1,331.50 | 1,148.40 - 1,148.40 |
| Zydus Lifesciences Ltd. | 1,04,542.68 | 1,073.50 | 835.50 - 835.50 |
| Lupin Ltd. | 1,04,222.36 | 2,285.00 | 1,836.80 - 1,836.80 |
| Mankind Pharma Ltd. | 1,02,422.13 | 2,459.05 | 1,909.70 - 1,909.70 |
| Max Healthcare Institute Ltd. | 99,587.17 | 1,000.05 | 903.00 - 903.00 |
No Records Found
With reference to the above and pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR), Zim Laboratories has informed that out of the approved investment amount of up to Rs 2.00 crore, the company has invested Rs 89.45 lakh which is 1,35,000 Australian Dollars in the equity shares of ZIMTAS. Post investment, the company holds 99.96% of the total share capital of ZIMTAS.
The above information is a part of company’s filings submitted to BSE.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202603 | 202503 | % Var | 202603 | 202503 | % Var | 202603 | 202503 | % Var | |
| Sales | 496.14 | 494.67 | 0.30 | 1129.82 | 1092.99 | 3.37 | 1129.82 | 1092.99 | 3.37 |
| Other Income | 1.73 | 0.49 | 253.06 | 2.86 | 13.09 | -78.15 | 2.86 | 13.09 | -78.15 |
| PBIDT | 2.87 | -19.05 | -115.07 | -150.80 | -87.76 | 71.83 | -150.80 | -87.76 | 71.83 |
| Interest | 18.08 | 21.28 | -15.04 | 47.77 | 19.61 | 143.60 | 47.77 | 19.61 | 143.60 |
| PBDT | -15.21 | -40.33 | -62.29 | -198.57 | -107.37 | 84.94 | -198.57 | -107.37 | 84.94 |
| Depreciation | -2.41 | -2.34 | 2.99 | 23.23 | 36.14 | -35.72 | 23.23 | 36.14 | -35.72 |
| PBT | -12.80 | -37.99 | -66.31 | -221.80 | -143.51 | 54.55 | -221.80 | -143.51 | 54.55 |
| TAX | 4.24 | -16.48 | -125.73 | -46.09 | -40.53 | 13.72 | -46.09 | -40.53 | 13.72 |
| Deferred Tax | 4.24 | -18.08 | -123.45 | -46.09 | -42.13 | 9.40 | -46.09 | -42.13 | 9.40 |
| PAT | -17.04 | -21.51 | -20.78 | -175.71 | -102.98 | 70.63 | -175.71 | -102.98 | 70.63 |
| Equity | 369.84 | 369.84 | 0.00 | 369.84 | 369.84 | 0.00 | 369.84 | 369.84 | 0.00 |
| PBIDTM(%) | 0.58 | -3.85 | -115.02 | -13.35 | -8.03 | 66.23 | -13.35 | -8.03 | 66.23 |
No Records Found
The current share price of Zim Laboratories Ltd. is ₹100.04 as of 2026-05-25.
The market capitalisation of Zim Laboratories Ltd. is ₹535.70 as of 2026-05-22.
The 1-year return of Zim Laboratories Ltd. is -0.12% as of 2026-05-25.
The P/E ratio of Zim Laboratories Ltd. is 32.12 as of 2026-05-25.
The 52-week high and low of Zim Laboratories Ltd. are ₹127.00 and ₹59.31, respectively, as of 2026-05-25.
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.